documents

Regulatory documents from Regulations.gov including rules, proposed rules, notices, and supporting materials.

Data license: Public Domain (U.S. Government data) · Data source: Federal Register API & Regulations.gov API

72 rows where docket_id = "FDA-1977-N-0224" and posted_year = 2010 sorted by posted_date descending

✎ View and edit SQL

This data as json, CSV (advanced)

Suggested facets: subtype, posted_date, posted_month, comment_start_date, posted_date (date), comment_start_date (date), comment_end_date (date), last_modified (date)

document_type 2

posted_year 1

  • 2010 · 72 ✖

agency_id 1

id agency_id docket_id title document_type subtype posted_date ▲ posted_year posted_month comment_start_date comment_end_date last_modified fr_doc_num open_for_comment withdrawn object_id
FDA-1977-N-0224-0123 FDA Tetracycline-Proposal to Revise Regulations FDA-1977-N-0224 Answer Letter from FDA to Comment from The Honorable Adlai E. Stevenson III, United States Senate Other Answer 2010-06-01T04:00:00Z 2010 6 2010-06-01T04:00:00Z   2019-04-15T12:19:24Z   0 0 09000064805ecf15
FDA-1977-N-0224-0135 FDA Tetracycline-Proposal to Revise Regulations FDA-1977-N-0224 Answer Letter from FDA to Comment from The Honorable Eldon Rudd, United States House of Representatives Other Answer 2010-06-01T04:00:00Z 2010 6 2010-06-01T04:00:00Z   2019-04-15T13:20:01Z   0 0 09000064805ecf1b
FDA-1977-N-0224-0114 FDA Tetracycline-Proposal to Revise Regulations FDA-1977-N-0224 Answer Letter from FDA to Comment from The Honorable Olin E. Teague, United States House of Representatives Other Answer 2010-06-01T04:00:00Z 2010 6 2010-06-01T04:00:00Z   2019-04-12T18:56:37Z   0 0 09000064805ecf0f
FDA-1977-N-0224-0137 FDA Tetracycline-Proposal to Revise Regulations FDA-1977-N-0224 Answer Letter from FDA to Comment from The Honorable Paul Laxalt, United States Senate Other Answer 2010-06-01T04:00:00Z 2010 6 2010-06-01T04:00:00Z   2019-04-15T13:34:12Z   0 0 09000064805ecf1d
FDA-1977-N-0224-0131 FDA Tetracycline-Proposal to Revise Regulations FDA-1977-N-0224 Answer Letter from FDA to Comment from The Honorable Russell Long, United States Senate Other Answer 2010-06-01T04:00:00Z 2010 6 2010-06-01T04:00:00Z   2019-04-15T12:57:55Z   0 0 09000064805ecf19
FDA-1977-N-0224-0127 FDA Tetracycline-Proposal to Revise Regulations FDA-1977-N-0224 Answer Letter from FDA to Comment from The Honorable Robert P. Griffin, United States Senate Other Answer 2010-06-01T04:00:00Z 2010 6 2010-06-01T04:00:00Z   2019-04-15T12:38:51Z   0 0 09000064805ecf17
FDA-1977-N-0224-0119 FDA Tetracycline-Proposal to Revise Regulations FDA-1977-N-0224 Answer Letter from FDA to Comment from The Honorable James T. Broyhill, United States House of Representatives Other Answer 2010-06-01T04:00:00Z 2010 6 2010-06-01T04:00:00Z   2019-04-15T11:52:16Z   0 0 09000064805ecf12
FDA-1977-N-0224-0125 FDA Tetracycline-Proposal to Revise Regulations FDA-1977-N-0224 Answer Letter from FDA to Comment from The Honorable Robert P. Griffin, United States Senate Other Answer 2010-06-01T04:00:00Z 2010 6 2010-06-01T04:00:00Z   2019-04-15T12:32:19Z   0 0 09000064805ecf16
FDA-1977-N-0224-0113 FDA Tetracycline-Proposal to Revise Regulations FDA-1977-N-0224 Answer from FDA to The Honorable Bill Alexander, United States House of Representatives Other Answer 2010-06-01T04:00:00Z 2010 6 2010-04-21T04:00:00Z 1977-09-30T03:59:59Z 2019-06-19T15:12:26Z   0 0 09000064805eceff
FDA-1977-N-0224-0133 FDA Tetracycline-Proposal to Revise Regulations FDA-1977-N-0224 Answer Letter from FDA to Comment from The Honorable Jake Garn, United States Senate Other Answer 2010-06-01T04:00:00Z 2010 6 2010-06-01T04:00:00Z   2019-04-15T13:12:01Z   0 0 09000064805ecf1a
FDA-1977-N-0224-0122 FDA Tetracycline-Proposal to Revise Regulations FDA-1977-N-0224 Answer Letter from FDA to Comment from The Honorable Adlai E. Stevenson III, United States Senate Other Answer 2010-06-01T04:00:00Z 2010 6 2010-06-01T04:00:00Z   2019-04-15T12:18:11Z   0 0 09000064805ecf14
FDA-1977-N-0224-0129 FDA Tetracycline-Proposal to Revise Regulations FDA-1977-N-0224 Answer Letter from FDA to Comment from The Honorable Edmund S. Muskie, United States Senate Other Answer 2010-06-01T04:00:00Z 2010 6 2010-06-01T04:00:00Z   2019-04-15T12:46:45Z   0 0 09000064805ecf18
FDA-1977-N-0224-0121 FDA Tetracycline-Proposal to Revise Regulations FDA-1977-N-0224 Answer Letter from FDA to Comment from The Honorable James M. Hanley, United States House of Representatives Other Answer 2010-06-01T04:00:00Z 2010 6 2010-06-01T04:00:00Z   2019-04-15T12:01:50Z   0 0 09000064805ecf13
FDA-1977-N-0224-0117 FDA Tetracycline-Proposal to Revise Regulations FDA-1977-N-0224 Answer Letter from FDA to Comment from The Honorable Ed Jones, United States House of Representatives Other Answer 2010-06-01T04:00:00Z 2010 6 2010-06-01T04:00:00Z   2019-04-12T19:47:41Z   0 0 09000064805ecf11
FDA-1977-N-0224-0112 FDA Tetracycline-Proposal to Revise Regulations FDA-1977-N-0224 Answer from FDA to The Honorable Trent Lott, United States House of Representatives Other Answer 2010-06-01T04:00:00Z 2010 6 2010-04-21T04:00:00Z 1977-09-30T03:59:59Z 2019-06-19T15:21:22Z   0 0 09000064805ecefe
FDA-1977-N-0224-0106 FDA Tetracycline-Proposal to Revise Regulations FDA-1977-N-0224 Answer Letter from FDA to The Honorable William M. Ketchum, United States House of Representatives Other Answer 2010-05-24T04:00:00Z 2010 5 2010-05-24T04:00:00Z   2019-04-12T19:11:46Z   0 0 09000064805ecf10
FDA-1977-N-0224-0097 FDA Tetracycline-Proposal to Revise Regulations FDA-1977-N-0224 Answer Letter from FDA to Comment from The Honorable Sam B. Hall, Jr., United States House of Representatives Other Answer 2010-04-26T04:00:00Z 2010 4 2010-04-21T04:00:00Z 1977-09-30T03:59:59Z 2019-06-19T13:48:47Z   0 0 09000064805ecf09
FDA-1977-N-0224-0076 FDA Tetracycline-Proposal to Revise Regulations FDA-1977-N-0224 Answer Letter from FDA to Comment from The Honorable Trent Lott, United States House of Representatives Other Answer 2010-04-26T04:00:00Z 2010 4 2010-04-21T04:00:00Z 1977-09-30T03:59:59Z 2019-06-19T15:25:30Z   0 0 09000064805ecefd
FDA-1977-N-0224-0085 FDA Tetracycline-Proposal to Revise Regulations FDA-1977-N-0224 Answer Letter from FDA to Comment from The Honorable Don Fuqua, United States House of Representatives Other Answer 2010-04-26T04:00:00Z 2010 4 2010-04-21T04:00:00Z 1977-09-30T03:59:59Z 2019-06-19T14:18:18Z   0 0 09000064805ecf03
FDA-1977-N-0224-0101 FDA Tetracycline-Proposal to Revise Regulations FDA-1977-N-0224 Answer Letter from FDA to Comment from The Honorable Floyd D. Spence, United States House of Representatives Other Answer 2010-04-26T04:00:00Z 2010 4 2010-04-21T04:00:00Z 1977-09-30T03:59:59Z 2019-06-19T13:25:54Z   0 0 09000064805ecf0c
FDA-1977-N-0224-0083 FDA Tetracycline-Proposal to Revise Regulations FDA-1977-N-0224 Answer Letter from FDA to Comment from The Honorable Birch Bayh, United States Senate Other Answer 2010-04-26T04:00:00Z 2010 4 2010-04-21T04:00:00Z 1977-09-30T03:59:59Z 2019-06-19T14:20:10Z   0 0 09000064805ecf02
FDA-1977-N-0224-0089 FDA Tetracycline-Proposal to Revise Regulations FDA-1977-N-0224 Answer Letter from FDA to Comment from The Honorable Dawson Mathis, United States House of Representatives Other Answer 2010-04-26T04:00:00Z 2010 4 2010-04-21T04:00:00Z 1977-09-30T03:59:59Z 2019-06-19T14:08:58Z   0 0 09000064805ecf05
FDA-1977-N-0224-0091 FDA Tetracycline-Proposal to Revise Regulations FDA-1977-N-0224 Answer Letter from FDA to Comment from The Honorable Bill Archer, United States House of Representatives Other Answer 2010-04-26T04:00:00Z 2010 4 2010-04-21T04:00:00Z 1977-09-30T03:59:59Z 2019-04-12T17:07:51Z   0 0 09000064805ecf06
FDA-1977-N-0224-0087 FDA Tetracycline-Proposal to Revise Regulations FDA-1977-N-0224 Answer Letter from FDA to Comment from The Honorable Dawson Mathis, United States House of Representatives Other Answer 2010-04-26T04:00:00Z 2010 4 2010-04-21T04:00:00Z 1977-09-30T03:59:59Z 2019-04-12T14:07:16Z   0 0 09000064805ecf04
FDA-1977-N-0224-0095 FDA Tetracycline-Proposal to Revise Regulations FDA-1977-N-0224 Answer Letter from FDA to Comment from The Honorable Sam B. Hall, Jr. United States House of Representatives Other Answer 2010-04-26T04:00:00Z 2010 4     2019-06-19T13:50:16Z   0 0 09000064805ecf08
FDA-1977-N-0224-0079 FDA Tetracycline-Proposal to Revise Regulations FDA-1977-N-0224 Answer Letter from FDA to Comment from The Honorable Richard G. Lugar, United States Senate Other Answer 2010-04-26T04:00:00Z 2010 4 2010-04-21T04:00:00Z 1977-09-30T03:59:59Z 2019-06-19T15:08:01Z   0 0 09000064805ecf00
FDA-1977-N-0224-0100 FDA Tetracycline-Proposal to Revise Regulations FDA-1977-N-0224 Answer Letter from FDA to Comment from The Honorable Floyd D. Spence, United States House of Representatives Other Answer 2010-04-26T04:00:00Z 2010 4 2010-04-21T04:00:00Z 1977-09-30T03:59:59Z 2019-06-18T18:50:01Z   0 0 09000064805ecf0b
FDA-1977-N-0224-0103 FDA Tetracycline-Proposal to Revise Regulations FDA-1977-N-0224 Answer Letter from FDA to Comment from The Honorable Bill Hefner, United States House of Representatives Other Answer 2010-04-26T04:00:00Z 2010 4 2010-04-21T04:00:00Z 1977-09-30T03:59:59Z 2019-06-18T18:44:11Z   0 0 09000064805ecf0d
FDA-1977-N-0224-0074 FDA Tetracycline-Proposal to Revise Regulations FDA-1977-N-0224 Answer Letter from FDA to Comment from The Honorable Trent Lott, United States House of Representatives Other Answer 2010-04-26T04:00:00Z 2010 4 2010-04-21T04:00:00Z 1977-09-30T03:59:59Z 2019-06-19T15:28:26Z   0 0 09000064805ecefc
FDA-1977-N-0224-0081 FDA Tetracycline-Proposal to Revise Regulations FDA-1977-N-0224 Answer Letter from FDA to Comment from The Honorable Gaylord Nelson, United States Senate Other Answer 2010-04-26T04:00:00Z 2010 4 2010-04-21T04:00:00Z 1977-09-30T03:59:59Z 2019-06-19T14:44:42Z   0 0 09000064805ecf01
FDA-1977-N-0224-0093 FDA Tetracycline-Proposal to Revise Regulations FDA-1977-N-0224 Answer Letter from FDA to Comment from The Honorable Bill Archer, United States House of Representatives Other Answer 2010-04-26T04:00:00Z 2010 4 2010-04-21T04:00:00Z 1977-09-30T03:59:59Z 2019-06-19T14:01:51Z   0 0 09000064805ecf07
FDA-1977-N-0224-0071 FDA Tetracycline-Proposal to Revise Regulations FDA-1977-N-0224 Answer Letter from FDA to Comment from the Honorable Robert W. Daniel Jr., United States House of Representatives Other Answer 2010-04-23T04:00:00Z 2010 4 2010-04-21T04:00:00Z 1977-09-30T03:59:59Z 2019-06-19T15:32:52Z   0 0 09000064805ecef9
FDA-1977-N-0224-0058 FDA Tetracycline-Proposal to Revise Regulations FDA-1977-N-0224 Answer Letter from FDA to Comment from The Honorable Richard S. Schweiker, United States Senate Other Answer 2010-04-23T04:00:00Z 2010 4 2010-04-21T04:00:00Z 1977-09-30T03:59:59Z 2019-06-19T15:51:32Z   0 0 09000064805ecef2
FDA-1977-N-0224-0049 FDA Tetracycline-Proposal to Revise Regulations FDA-1977-N-0224 Answer Letter from FDA to Comment from The Honorable John Tower, United States Senate Other Answer 2010-04-23T04:00:00Z 2010 4 2010-04-21T04:00:00Z 1977-09-30T03:59:59Z 2019-06-19T16:11:03Z   0 0 09000064805eceec
FDA-1977-N-0224-0045 FDA Tetracycline-Proposal to Revise Regulations FDA-1977-N-0224 Answer Letter from FDA to Comment from The Honorable Robert A. Roe, United States House of Representatives Other Answer 2010-04-23T04:00:00Z 2010 4 2010-04-21T04:00:00Z 1977-09-30T03:59:59Z 2019-06-19T18:21:05Z   0 0 09000064805eceea
FDA-1977-N-0224-0062 FDA Tetracycline-Proposal to Revise Regulations FDA-1977-N-0224 Answer Letter from FDA to Comment from The Honorable Don H. Clausen, United States House of Representatives Other Answer 2010-04-23T04:00:00Z 2010 4 2010-04-21T04:00:00Z 1977-09-30T03:59:59Z 2019-06-19T15:40:51Z   0 0 09000064805ecef4
FDA-1977-N-0224-0065 FDA Tetracycline-Proposal to Revise Regulations FDA-1977-N-0224 Answer Letter from FDA to Comment from The Honorable Edward Zorinsky, United States Senate Other Answer 2010-04-23T04:00:00Z 2010 4 2010-04-21T04:00:00Z 1977-09-30T03:59:59Z 2019-06-19T15:38:41Z   0 0 09000064805ecef6
FDA-1977-N-0224-0047 FDA Tetracycline-Proposal to Revise Regulations FDA-1977-N-0224 Answer Letter from FDA to Comment from The Honorable James R. Jones, United States House of Representatives Other Answer 2010-04-23T04:00:00Z 2010 4 2010-04-21T04:00:00Z 1977-09-30T03:59:59Z 2019-06-19T16:16:09Z   0 0 09000064805eceeb
FDA-1977-N-0224-0055 FDA Tetracycline-Proposal to Revise Regulations FDA-1977-N-0224 Answer Letter from FDA to Comment from The Honorable Doug Barnard, Jr., United States House of Representatives Other Answer 2010-04-23T04:00:00Z 2010 4 2010-04-21T04:00:00Z 1977-09-30T03:59:59Z 2019-06-19T16:04:34Z   0 0 09000064805ecef0
FDA-1977-N-0224-0042 FDA Tetracycline-Proposal to Revise Regulations FDA-1977-N-0224 Answer Letter from FDA to Comment from The Honorable E. Thomas Coleman, United States House of Representatives Other Answer 2010-04-23T04:00:00Z 2010 4 2010-04-21T04:00:00Z 1977-09-30T03:59:59Z 2019-06-19T18:27:21Z   0 0 09000064805ecee8
FDA-1977-N-0224-0050 FDA Tetracycline-Proposal to Revise Regulations FDA-1977-N-0224 Answer Letter from FDA to Comment from The Honorable Carl T. Curtis, United States Senate Other Answer 2010-04-23T04:00:00Z 2010 4 2010-04-21T04:00:00Z 1977-09-30T03:59:59Z 2019-04-11T15:25:44Z   0 0 09000064805eceed
FDA-1977-N-0224-0069 FDA Tetracycline-Proposal to Revise Regulations FDA-1977-N-0224 Answer Letter from FDA to Comment from The Honorable William L. Armstrong, United States House of Representatives Other Answer 2010-04-23T04:00:00Z 2010 4 2010-04-21T04:00:00Z 1977-09-30T03:59:59Z 2019-06-19T15:34:18Z   0 0 09000064805ecef8
FDA-1977-N-0224-0057 FDA Tetracycline-Proposal to Revise Regulations FDA-1977-N-0224 Answer Letter from FDA to Comment from The Honorable Robert J. Lagomarsino, United States House of Representatives Other Answer 2010-04-23T04:00:00Z 2010 4 2010-04-21T04:00:00Z 1977-09-30T03:59:59Z 2019-06-19T15:58:15Z   0 0 09000064805ecef1
FDA-1977-N-0224-0064 FDA Tetracycline-Proposal to Revise Regulations FDA-1977-N-0224 Answer Letter from FDA to Comment from The Honorable William L. Dickinson, United States House of Representatives Other Answer 2010-04-23T04:00:00Z 2010 4 2010-04-21T04:00:00Z 1977-09-30T03:59:59Z 2019-06-19T15:39:52Z   0 0 09000064805ecef5
FDA-1977-N-0224-0060 FDA Tetracycline-Proposal to Revise Regulations FDA-1977-N-0224 Answer Letter from FDA to Comment from The Honorable James C. Corman, United States House of Representatives Other Answer 2010-04-23T04:00:00Z 2010 4 2010-04-21T04:00:00Z 1977-09-30T03:59:59Z 2019-06-19T15:46:27Z   0 0 09000064805ecef3
FDA-1977-N-0224-0053 FDA Tetracycline-Proposal to Revise Regulations FDA-1977-N-0224 Answer Letter from FDA to Comment from The Honorable Jesse Helms, United States Senate Other Answer 2010-04-23T04:00:00Z 2010 4 2010-04-21T04:00:00Z 1977-09-30T03:59:59Z 2019-06-19T16:06:21Z   0 0 09000064805eceee
FDA-1977-N-0224-0073 FDA Tetracycline-Proposal to Revise Regulations FDA-1977-N-0224 Answer Letter from FDA to Comment from The Honorable William L. Dickinson, United States House of Representatives Other Answer 2010-04-23T04:00:00Z 2010 4 2010-04-21T04:00:00Z 1977-09-30T03:59:59Z 2019-06-20T13:49:42Z   0 0 09000064805ecefa
FDA-1977-N-0224-0067 FDA Tetracycline-Proposal to Revise Regulations FDA-1977-N-0224 Answer Letter from FDA to Comment from The Honorable James D. Santini, United States House of Representatives Other Answer 2010-04-23T04:00:00Z 2010 4 2010-04-21T04:00:00Z 1977-09-30T03:59:59Z 2019-06-19T15:37:17Z   0 0 09000064805ecef7
FDA-1977-N-0224-0044 FDA Tetracycline-Proposal to Revise Regulations FDA-1977-N-0224 Answer Letter from FDA to Comment from The Honorable W. R. Poage, United States House of Representatives Other Answer 2010-04-23T04:00:00Z 2010 4 2010-04-21T04:00:00Z 1977-09-30T03:59:59Z 2019-06-19T18:24:19Z   0 0 09000064805ecee9
FDA-1977-N-0224-0030 FDA Tetracycline-Proposal to Revise Regulations FDA-1977-N-0224 Answer Letter from FDA to Comment from The Honorable Harrison A. Williams, Jr., United States Senate Other Answer 2010-04-22T04:00:00Z 2010 4 2010-04-21T04:00:00Z 1977-09-30T03:59:59Z 2019-06-19T19:24:11Z   0 0 09000064805ecee0
FDA-1977-N-0224-0029 FDA Tetracycline-Proposal to Revise Regulations FDA-1977-N-0224 Answer Letter from FDA to Comment from The Honorable Ray Roberts, United States House of Representatives Other Answer 2010-04-22T04:00:00Z 2010 4 2010-04-21T04:00:00Z 1977-09-30T03:59:59Z 2019-06-19T19:28:39Z   0 0 09000064805ecedf
FDA-1977-N-0224-0036 FDA Tetracycline-Proposal to Revise Regulations FDA-1977-N-0224 Answer Letter from FDA to Comment from The Honorable Mark O. Hatfield, United States Senate Other Answer 2010-04-22T04:00:00Z 2010 4 2010-04-21T04:00:00Z 1977-09-30T03:59:59Z 2019-06-19T19:18:08Z   0 0 09000064805ecee3
FDA-1977-N-0224-0038 FDA Tetracycline-Proposal to Revise Regulations FDA-1977-N-0224 Answer Letter from FDA to Comment from The Honorable Thad Cochran, United States House of Representatives Other Answer 2010-04-22T04:00:00Z 2010 4 2010-04-21T04:00:00Z 1977-09-30T03:59:59Z 2019-06-19T18:56:37Z   0 0 09000064805ecee5
FDA-1977-N-0224-0034 FDA Tetracycline-Proposal to Revise Regulations FDA-1977-N-0224 Answer Letter from FDA to Comment from The Honorable Bill Frenzel, United States House of Representatives Other Answer 2010-04-22T04:00:00Z 2010 4 2010-04-21T04:00:00Z 1977-09-30T03:59:59Z 2019-06-19T19:19:32Z   0 0 09000064805ecee2
FDA-1977-N-0224-0037 FDA Tetracycline-Proposal to Revise Regulations FDA-1977-N-0224 Answer Letter from FDA to Comment from The Honorable David R. Bowen, United States House of Representatives Other Answer 2010-04-22T04:00:00Z 2010 4 2010-04-21T04:00:00Z 1977-09-30T03:59:59Z 2019-06-19T19:15:02Z   0 0 09000064805ecee4
FDA-1977-N-0224-0040 FDA Tetracycline-Proposal to Revise Regulations FDA-1977-N-0224 Answer Letter from FDA to Comment from The Honorable Gillespie V. Montgomery, United States House of Representatives Other Answer 2010-04-22T04:00:00Z 2010 4 2010-04-21T04:00:00Z 1977-09-30T03:59:59Z 2019-06-19T18:30:52Z   0 0 09000064805ecee6
FDA-1977-N-0224-0032 FDA Tetracycline-Proposal to Revise Regulations FDA-1977-N-0224 Answer Letter from FDA to Comment from The Honorable Harrison A. Williams, Jr., United States Senate Other Answer 2010-04-22T04:00:00Z 2010 4 2010-04-21T04:00:00Z 1977-09-30T03:59:59Z 2019-06-19T19:21:52Z   0 0 09000064805ecee1
FDA-1977-N-0224-0022 FDA Tetracycline-Proposal to Revise Regulations FDA-1977-N-0224 Answer Letter from FDA to Comment from The Honorable John Sparkman, United States Senate Other Answer 2010-04-21T04:00:00Z 2010 4 2010-04-21T04:00:00Z 1977-09-30T03:59:59Z 2019-06-19T19:57:33Z   0 0 09000064805ecedb
FDA-1977-N-0224-0013 FDA Tetracycline-Proposal to Revise Regulations FDA-1977-N-0224 Answer Letter from FDA to Comment from The Honorable E (Kika) de la Garza, United States House of Representatives Other Answer 2010-04-21T04:00:00Z 2010 4 2010-04-21T04:00:00Z 1977-09-30T03:59:59Z 2019-06-19T20:26:55Z   0 0 09000064805eced5
FDA-1977-N-0224-0020 FDA Tetracycline-Proposal to Revise Regulations FDA-1977-N-0224 Answer Letter from FDA to Comment from The Honorable Richard (Dick) Stone, United States Senate Other Answer 2010-04-21T04:00:00Z 2010 4 2010-04-21T04:00:00Z 1977-09-30T03:59:59Z 2019-06-19T20:00:23Z   0 0 09000064805eceda
FDA-1977-N-0224-0005 FDA Tetracycline-Proposal to Revise Regulations FDA-1977-N-0224 Answer Letter from FDA to Comment from The Honorable William H. Natcher, United States House of Representatives Other Answer 2010-04-21T04:00:00Z 2010 4 2010-04-21T04:00:00Z 1977-09-30T03:59:59Z 2019-06-20T13:58:54Z   0 0 09000064805eced1
FDA-1977-N-0224-0023 FDA Tetracycline-Proposal to Revise Regulations FDA-1977-N-0224 Answer Letter from FDA to Comment from The Honorable John Sparkman, United States Senate Other Answer 2010-04-21T04:00:00Z 2010 4 2010-04-21T04:00:00Z 1977-09-30T03:59:59Z 2019-06-19T19:53:59Z   0 0 09000064805ecedc
FDA-1977-N-0224-0011 FDA Tetracycline-Proposal to Revise Regulations FDA-1977-N-0224 Answer Letter from FDA to Comment from The Honorable Dick Clark, United States Senate Other Answer 2010-04-21T04:00:00Z 2010 4 2010-04-21T04:00:00Z 1977-09-30T03:59:59Z 2019-06-19T20:41:27Z   0 0 09000064805eced4
FDA-1977-N-0224-0017 FDA Tetracycline-Proposal to Revise Regulations FDA-1977-N-0224 Answer Letter from FDA to Comment from The Honorable James Abdnor, United States House of Representatives Other Answer 2010-04-21T04:00:00Z 2010 4 2010-04-21T04:00:00Z 1977-09-30T03:59:59Z 2019-06-19T20:15:47Z   0 0 09000064805eced8
FDA-1977-N-0224-0018 FDA Tetracycline-Proposal to Revise Regulations FDA-1977-N-0224 Answer Letter from FDA to Comment from The Honorable Clifford P. Case, United States Senate Other Answer 2010-04-21T04:00:00Z 2010 4 2010-04-21T04:00:00Z 1977-09-30T03:59:59Z 2019-06-19T20:12:03Z   0 0 09000064805eced9
FDA-1977-N-0224-0007 FDA Tetracycline-Proposal to Revise Regulations FDA-1977-N-0224 Answer Letter from FDA to Comment from The Honorable Charles E. Bennett, United States House of Representatives Other Answer 2010-04-21T04:00:00Z 2010 4 2010-04-21T04:00:00Z 1977-09-30T03:59:59Z 2019-06-20T13:57:08Z   0 0 09000064805eced2
FDA-1977-N-0224-0015 FDA Tetracycline-Proposal to Revise Regulations FDA-1977-N-0224 Answer Letter from FDA to Comment from The Honorable Abraham Kazen, Jr., United States House of Representatives Other Answer 2010-04-21T04:00:00Z 2010 4 2010-04-21T04:00:00Z 1977-09-30T03:59:59Z 2019-06-19T20:18:19Z   0 0 09000064805eced7
FDA-1977-N-0224-0003 FDA Tetracycline-Proposal to Revise Regulations FDA-1977-N-0224 Answer Letter from FDA to Comment from The Honorable Tom Hagedorn, United States House of Representatives Other Answer 2010-04-21T04:00:00Z 2010 4 2010-04-21T04:00:00Z 1977-09-30T03:59:59Z 2019-06-20T14:04:07Z   0 0 09000064805eced0
FDA-1977-N-0224-0025 FDA Tetracycline-Proposal to Revise Regulations FDA-1977-N-0224 Answer Letter from FDA to Comment from The Honorable Harold Runnels, United States House of Representatives Other Answer 2010-04-21T04:00:00Z 2010 4 2010-04-21T04:00:00Z 1977-09-30T03:59:59Z 2019-06-19T19:50:34Z   0 0 09000064805ecedd
FDA-1977-N-0224-0001 FDA Tetracycline-Proposal to Revise Regulations FDA-1977-N-0224 Chlortetracycline and Oxtetracycline In Animal Feeds Notice Of Proposed Rule Making Proposed Rule Notice of Proposed Rulemaking (NPRM) 2010-04-21T04:00:00Z 2010 4 2010-04-21T04:00:00Z 1977-09-30T03:59:59Z 2019-04-30T01:02:53Z 77-30563 0 0 09000064805ec934
FDA-1977-N-0224-0009 FDA Tetracycline-Proposal to Revise Regulations FDA-1977-N-0224 Answer Letter from FDA to Comment from The Honorable Lloyd Bentsen, United States Senate Other Answer 2010-04-21T04:00:00Z 2010 4 2010-04-21T04:00:00Z 1977-09-30T03:59:59Z 2019-06-19T20:45:27Z   0 0 09000064805eced3
FDA-1977-N-0224-0026 FDA Tetracycline-Proposal to Revise Regulations FDA-1977-N-0224 Answer Letter from FDA to Comment from The Honorable Don Fuqua, United States House of Representatives Other Answer 2010-04-21T04:00:00Z 2010 4 2010-04-21T04:00:00Z 1977-09-30T03:59:59Z 2019-06-19T19:48:34Z   0 0 09000064805ecede

Advanced export

JSON shape: default, array, newline-delimited, object

CSV options: 

CREATE TABLE documents (
    id TEXT PRIMARY KEY,
    agency_id TEXT,
    docket_id TEXT REFERENCES dockets(id),
    title TEXT,
    document_type TEXT,
    subtype TEXT,
    posted_date TEXT,
    posted_year INTEGER,
    posted_month INTEGER,
    comment_start_date TEXT,
    comment_end_date TEXT,
    last_modified TEXT,
    fr_doc_num TEXT,
    open_for_comment INTEGER,
    withdrawn INTEGER,
    object_id TEXT
);
CREATE INDEX idx_docs_agency ON documents(agency_id);
CREATE INDEX idx_docs_docket ON documents(docket_id);
CREATE INDEX idx_docs_date ON documents(posted_date);
CREATE INDEX idx_docs_year ON documents(posted_year);
CREATE INDEX idx_docs_type ON documents(document_type);
CREATE INDEX idx_docs_frnum ON documents(fr_doc_num);